Alzheimer's Treatment

Alzheimer's Treatment with TPS
It is a treatment protocol used to stimulate brain regions with reduced function in patients with Alzheimer's disease.

The diagnosis of Alzheimer's disease is a devastating process for both the patient and their relatives. Despite intensive research, a cure for Alzheimer's has not yet been found, but progress has been made in the fight against the disease. The quality of life and self-determination of those affected by this disease should be preserved for as long as possible.

Drug therapies for Alzheimer's disease are of very limited benefit in the progression of the disease.

Trancranial Pulse Stimulation (TPS) has been developed as a new treatment for Alzheimer's Disease by the University of Wienna in Austria, the University of Toronto in Canada and Swiss organizations.

NeuroUp treatment protocol with Transcranial Pulse Stimulation TPS will start to be applied at NeuroUpClinic for the first time in our country almost at the same time with the centers in developed countries around the world. The current treatment is currently used in Austria, Switzerland, Germany, England, Hongkong, Spain, Portugal, Denmark.

The TPS neural stimulation technique, developed by an international consortium led by Vienna, is a technique that can activate deep areas of the brain in a targeted and non-invasive way.

Therefore, it is still used to restore impaired brain function by activating functional neurons.

A new treatment for Alzheimer's Disease!
The diagnosis of Alzheimer's Disease brings with it many challenges, both for the person with the disease and for all the relatives of the patient. Despite the best efforts of medical science, Alzheimer's Disease remains incurable. Some drugs have had limited success in the fight against Alzheimer's disease.

It has been shown that drug treatments known as acetyl cholinesterase inhibitors can help stabilize mental performance and slow Alzheimer's symptoms by working to prevent the breakdown of acetylcholine, a chemical in the brain believed to play an important role in memory and thinking functions.

Similarly, NMDA receptor antagonists are also used as an adjunct.
At the Clinic, we offer *NeuroUp*, a non-invasive treatment that uses Transcranial Pulse Stimulation (TPS) technology to improve the quality of life for patients suffering from mild to moderate AD, at almost the same time as major neurology treatment centers around the world.

Transcranial Pulse Stimulation (TPS) is safe. The patient sits comfortably in the treatment chair and can move freely at any time. Before the treatment begins, the doctor enters the patient data into the therapy system and applies ultrasound gel to the scalp or hair. It is not necessary to shave the patient's head.

The ultrasound gel is necessary to ensure optimal transmission of the pulses. The patient then wears a pair of glasses so that the position of the head can be determined. During the treatment, the doctor gently moves the handpiece over the relevant areas of the scalp and skull.

On a screen, both doctor and patient can see exactly which area of the brain is being reached. A therapy session usually lasts about 30 minutes. In general, a TPS treatment series includes an average of 6 sessions, all taking place within 2 weeks.